Bannière

Librairie

Isocitrate Dehydrogenase 1 Mutation Status of Low-Grade Gliomas Prediction from Radiomics Biomarkers of Conventional MRI scans

Présenté par

Mojtaba Safari

En ligne

Retraite annuelle

Isocitrate Dehydrogenase 1 Mutation Status of Low-Grade Gliomas Prediction from Radiomics Biomarkers of Conventional MRI scans

In 2016, the world health organization recommended using genotypic information such as isocitrate dehydrogenase (IDH) mutation status for grading and treatment planning of the central nervous system cancers such as low-grade gliomas. This presentation proposes a machine learning technique to predict Isocitrate dehydrogenase 1 (IDH 1) gene mutation status from T1, T1-Gd, T2, and T2-fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI) sequences. 

 

Biography


Mojtaba Safari is a Ph.D. student at Medical Physics program at the Département de physique, de génie physique et d'optique in the Université Laval. Mojtaba is doing Ph.D. under the supervision of Louis Archambault. 

Mojtaba is interested in MRI physics and quantitative MRI sequences. He is also passionate about machine learning (ML) applications in medical imaging. He has done some projects on quantitative MRI sequences radiomics biomarkers for predicting brain tumor type and grade.
 

Retraite annuelle

Activities

Discover

Featured project

Effect of oxygen pressure in cancerous tissue cells on radiotherapy treatments

Student member : Corinne Chouinard

Radiotherapy treatments currently used in the clinical field are rarely modified. They generally consist of a global therapy of 50 grays, fractionated in five treatments of two grays every week for five weeks.
Thus, it could be worthwhile to develop a numeric tool, based on mathematical models found in the literature, in order to compare different types of treatment without having to test them on real tissues. Several parameters are known to alter the tissue response after irradiation including oxygen

Read more